CC
CTIC
Caxton Corporation’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,239,300
| Closed | -$5.55M | – | 52 |
|
|
2021
Q4 | $5.55M | Buy |
2,239,300
+1,239,300
| +124% | +$3.07M | 4.54% | 9 |
|
|
2021
Q3 | $2.95M | Sell |
1,000,000
-1,314,533
| -57% | -$3.88M | 2.39% | 10 |
|
|
2021
Q2 | $5.79M | Sell |
2,314,533
-200,114
| -8% | -$500K | 3.96% | 10 |
|
|
2021
Q1 | $7.32M | Sell |
2,514,647
-1,235,243
| -33% | -$3.59M | 4.75% | 8 |
|
|
2020
Q4 | $12.1M | Sell |
3,749,890
-563,727
| -13% | -$1.82M | 7.53% | 4 |
|
|
2020
Q3 | $9.27M | Buy |
4,313,617
+3,694,157
| +596% | +$7.94M | 8.74% | 4 |
|
|
2020
Q2 | $719K | Buy |
619,460
+2,765
| +0.4% | +$3.21K | 0.76% | 12 |
|
|
2020
Q1 | $567K | Buy |
616,695
+291,085
| +89% | +$268K | 0.62% | 10 |
|
|
2019
Q4 | $514K | Buy |
325,610
+425
| +0.1% | +$671 | 0.5% | 14 |
|
|
2019
Q3 | $272K | Buy |
325,185
+733
| +0.2% | +$613 | 0.31% | 16 |
|
|
2019
Q2 | $279K | Buy |
324,452
+1,426
| +0.4% | +$1.23K | 0.32% | 15 |
|
|
2019
Q1 | $313K | Buy |
323,026
+199,085
| +161% | +$193K | 0.29% | 16 |
|
|
2018
Q4 | $91K | Sell |
123,941
-73,518
| -37% | -$54K | 0.11% | 25 |
|
|
2018
Q3 | $427K | Buy |
+197,459
| New | +$427K | 0.39% | 17 |
|